Table 2

Changes in Mental Component Score (MCS) after 6 and 12 months of FSL-FGM use in different subgroups

Baseline
(A)
6 months
(B)
12 months
(C)
P value
A vs B
P value
A vs C
MCS48.5±10.250.7±9.951.3±9.9<0.001<0.001
n674674674
MCS in women47.1±10.448.9±9.849.6±10.20.030.003
n329329329
MCS in men49.9±9.952.4±9.752.9±9.20.001<0.001
n345345345
MCS in persons with a baseline MCS ≤4536.9±6.043.4±9.444.2±9.9<0.001<0.001
n235235235
MCS in women with a baseline MCS ≤4536.9±6.042.9±9.343.6±10.4<0.001<0.001
n137137137
MCS in men with a baseline MCS ≤4537.0±6.044.0±9.645.2±9.2<0.001<0.001
n989898
MCS in persons with a baseline MCS >4554.8±5.554.6±7.655.1±7.40.870.87
n439439439
MCS in persons with type 1 DM48.3±10.350.6±10.051.5±9.9<0.001<0.001
n527527527
MCS in persons with type 2 DM48.5±10.250.4±9.750.5±9.40.490.46
n989898
MCS in persons with an HbA1c ≤53 mmol/mol48.4±10.551.7±10.051.9±9.90.0050.004
n176176176
MCS in persons with an HbA1c >53 mmol/mol48.6±10.150.4±9.851.2±9.80.010.001
n497497497
MCS in persons with HbA1c >64 mmol/mol48.9±10.250.1±9.951.1±10.30.360.04
n251251251
  • Data are presented as mean±SD.

  • DM, diabetes mellitus; FSL-FGM, FreeStyle Libre flash glucose monitoring.